Research ArticleArticle
The Direct Economic Burden of Gout in an Elderly Canadian Population
Aren Fischer, Michel Cloutier, Jason Goodfield, Richard Borrelli, Dawn Marvin and Alison Dziarmaga
The Journal of Rheumatology November 2016, jrheum.160300; DOI: https://doi.org/10.3899/jrheum.160300
Aren Fischer
From IMS Health Brogan, and AstraZeneca Canada, Mississauga, Ontario, Canada. Sponsorship and article processing charges for this study were provided by AstraZeneca Canada. A. Fischer, M. Cloutier, J. Goodfield, and R. Borrelli are employees of IMS Health Brogan. IMS Health Brogan is a consulting company that has received research grants from AstraZeneca Canada. A. Dziarmaga and D. Marvin are employees of AstraZeneca Canada. A. Fischer, MSc, IMS Health Brogan; M. Cloutier, PhD, IMS Health Brogan; J. Goodfield, BSc, BA, IMS Health Brogan; R. Borrelli, MBA, IMS Health Brogan; D. Marvin, MSc, AstraZeneca Canada; A. Dziarmaga, PhD, AstraZeneca Canada. Address correspondence to A. Fischer, IMS Brogan, 6700 Century Ave., Mississauga, Ontario L5N 6A4, Canada. E-mail: aren.fischer@ca.imsbrogan.com. Accepted for publication September 13, 2016.
Michel Cloutier
From IMS Health Brogan, and AstraZeneca Canada, Mississauga, Ontario, Canada. Sponsorship and article processing charges for this study were provided by AstraZeneca Canada. A. Fischer, M. Cloutier, J. Goodfield, and R. Borrelli are employees of IMS Health Brogan. IMS Health Brogan is a consulting company that has received research grants from AstraZeneca Canada. A. Dziarmaga and D. Marvin are employees of AstraZeneca Canada. A. Fischer, MSc, IMS Health Brogan; M. Cloutier, PhD, IMS Health Brogan; J. Goodfield, BSc, BA, IMS Health Brogan; R. Borrelli, MBA, IMS Health Brogan; D. Marvin, MSc, AstraZeneca Canada; A. Dziarmaga, PhD, AstraZeneca Canada. Address correspondence to A. Fischer, IMS Brogan, 6700 Century Ave., Mississauga, Ontario L5N 6A4, Canada. E-mail: aren.fischer@ca.imsbrogan.com. Accepted for publication September 13, 2016.
Jason Goodfield
From IMS Health Brogan, and AstraZeneca Canada, Mississauga, Ontario, Canada. Sponsorship and article processing charges for this study were provided by AstraZeneca Canada. A. Fischer, M. Cloutier, J. Goodfield, and R. Borrelli are employees of IMS Health Brogan. IMS Health Brogan is a consulting company that has received research grants from AstraZeneca Canada. A. Dziarmaga and D. Marvin are employees of AstraZeneca Canada. A. Fischer, MSc, IMS Health Brogan; M. Cloutier, PhD, IMS Health Brogan; J. Goodfield, BSc, BA, IMS Health Brogan; R. Borrelli, MBA, IMS Health Brogan; D. Marvin, MSc, AstraZeneca Canada; A. Dziarmaga, PhD, AstraZeneca Canada. Address correspondence to A. Fischer, IMS Brogan, 6700 Century Ave., Mississauga, Ontario L5N 6A4, Canada. E-mail: aren.fischer@ca.imsbrogan.com. Accepted for publication September 13, 2016.
Richard Borrelli
From IMS Health Brogan, and AstraZeneca Canada, Mississauga, Ontario, Canada. Sponsorship and article processing charges for this study were provided by AstraZeneca Canada. A. Fischer, M. Cloutier, J. Goodfield, and R. Borrelli are employees of IMS Health Brogan. IMS Health Brogan is a consulting company that has received research grants from AstraZeneca Canada. A. Dziarmaga and D. Marvin are employees of AstraZeneca Canada. A. Fischer, MSc, IMS Health Brogan; M. Cloutier, PhD, IMS Health Brogan; J. Goodfield, BSc, BA, IMS Health Brogan; R. Borrelli, MBA, IMS Health Brogan; D. Marvin, MSc, AstraZeneca Canada; A. Dziarmaga, PhD, AstraZeneca Canada. Address correspondence to A. Fischer, IMS Brogan, 6700 Century Ave., Mississauga, Ontario L5N 6A4, Canada. E-mail: aren.fischer@ca.imsbrogan.com. Accepted for publication September 13, 2016.
Dawn Marvin
From IMS Health Brogan, and AstraZeneca Canada, Mississauga, Ontario, Canada. Sponsorship and article processing charges for this study were provided by AstraZeneca Canada. A. Fischer, M. Cloutier, J. Goodfield, and R. Borrelli are employees of IMS Health Brogan. IMS Health Brogan is a consulting company that has received research grants from AstraZeneca Canada. A. Dziarmaga and D. Marvin are employees of AstraZeneca Canada. A. Fischer, MSc, IMS Health Brogan; M. Cloutier, PhD, IMS Health Brogan; J. Goodfield, BSc, BA, IMS Health Brogan; R. Borrelli, MBA, IMS Health Brogan; D. Marvin, MSc, AstraZeneca Canada; A. Dziarmaga, PhD, AstraZeneca Canada. Address correspondence to A. Fischer, IMS Brogan, 6700 Century Ave., Mississauga, Ontario L5N 6A4, Canada. E-mail: aren.fischer@ca.imsbrogan.com. Accepted for publication September 13, 2016.
Alison Dziarmaga
From IMS Health Brogan, and AstraZeneca Canada, Mississauga, Ontario, Canada. Sponsorship and article processing charges for this study were provided by AstraZeneca Canada. A. Fischer, M. Cloutier, J. Goodfield, and R. Borrelli are employees of IMS Health Brogan. IMS Health Brogan is a consulting company that has received research grants from AstraZeneca Canada. A. Dziarmaga and D. Marvin are employees of AstraZeneca Canada. A. Fischer, MSc, IMS Health Brogan; M. Cloutier, PhD, IMS Health Brogan; J. Goodfield, BSc, BA, IMS Health Brogan; R. Borrelli, MBA, IMS Health Brogan; D. Marvin, MSc, AstraZeneca Canada; A. Dziarmaga, PhD, AstraZeneca Canada. Address correspondence to A. Fischer, IMS Brogan, 6700 Century Ave., Mississauga, Ontario L5N 6A4, Canada. E-mail: aren.fischer@ca.imsbrogan.com. Accepted for publication September 13, 2016.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
The Direct Economic Burden of Gout in an Elderly Canadian Population
Aren Fischer, Michel Cloutier, Jason Goodfield, Richard Borrelli, Dawn Marvin, Alison Dziarmaga
The Journal of Rheumatology Nov 2016, jrheum.160300; DOI: 10.3899/jrheum.160300